167 related articles for article (PubMed ID: 10451348)
21. ETS1 lowers capillary endothelial cell density at confluence and induces the expression of VE-cadherin.
Lelièvre E; Mattot V; Huber P; Vandenbunder B; Soncin F
Oncogene; 2000 May; 19(20):2438-46. PubMed ID: 10828886
[TBL] [Abstract][Full Text] [Related]
22. Ets oncogene family.
Dhulipal PD
Indian J Exp Biol; 1997 Apr; 35(4):315-22. PubMed ID: 9315229
[TBL] [Abstract][Full Text] [Related]
23. Importance of ets1 proto-oncogene for breast cancer progression.
Dittmer J; Vetter M; Blumenthal SG; Lindemann RK; Kölbl H
Zentralbl Gynakol; 2004 Aug; 126(4):269-71. PubMed ID: 15389378
[TBL] [Abstract][Full Text] [Related]
24. The GATA-1 and Spi-1 transcriptional factors bind to a GATA/EBS dual element in the Fli-1 exon 1.
Barbeau B; Barat C; Bergeron D; Rassart E
Oncogene; 1999 Sep; 18(40):5535-45. PubMed ID: 10523830
[TBL] [Abstract][Full Text] [Related]
25. Ets motifs are necessary for endothelial cell-specific expression of a 723-bp Tie-2 promoter/enhancer in Hprt targeted transgenic mice.
Minami T; Kuivenhoven JA; Evans V; Kodama T; Rosenberg RD; Aird WC
Arterioscler Thromb Vasc Biol; 2003 Nov; 23(11):2041-7. PubMed ID: 12893685
[TBL] [Abstract][Full Text] [Related]
26. Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway.
Paumelle R; Tulasne D; Kherrouche Z; Plaza S; Leroy C; Reveneau S; Vandenbunder B; Fafeur V
Oncogene; 2002 Apr; 21(15):2309-19. PubMed ID: 11948414
[TBL] [Abstract][Full Text] [Related]
27. Expression of an Ets-1 dominant-negative mutant perturbs normal and tumor angiogenesis in a mouse ear model.
Pourtier-Manzanedo A; Vercamer C; Van Belle E; Mattot V; Mouquet F; Vandenbunder B
Oncogene; 2003 Mar; 22(12):1795-806. PubMed ID: 12660815
[TBL] [Abstract][Full Text] [Related]
28. Lymphatics and vascular channels; the differences behind similarity.
Jones PF
J Pathol; 2003 Aug; 200(5):551-2. PubMed ID: 12898589
[TBL] [Abstract][Full Text] [Related]
29. Effects of overexpression of the Ets family transcription factor TEL on cell growth and differentiation of K562 cells.
Sakurai T; Yamada T; Kihara-Negishi F; Teramoto S; Sato Y; Izawa T; Oikawa T
Int J Oncol; 2003 Jun; 22(6):1327-33. PubMed ID: 12739001
[TBL] [Abstract][Full Text] [Related]
30. High-affinity DNA-protein interactions of the cellular ETS1 protein: the determination of the ETS binding motif.
Fisher RJ; Mavrothalassitis G; Kondoh A; Papas TS
Oncogene; 1991 Dec; 6(12):2249-54. PubMed ID: 1766672
[TBL] [Abstract][Full Text] [Related]
31. Ets-1 and Ets-2 transcription factors are essential for normal coronary and myocardial development in chicken embryos.
Lie-Venema H; Gittenberger-de Groot AC; van Empel LJ; Boot MJ; Kerkdijk H; de Kant E; DeRuiter MC
Circ Res; 2003 Apr; 92(7):749-56. PubMed ID: 12637368
[TBL] [Abstract][Full Text] [Related]
32. Ets-1 and Ets-2 proto-oncogenes exhibit differential and restricted expression patterns during Xenopus laevis oogenesis and embryogenesis.
Meyer D; Durliat M; Senan F; Wolff M; Andre M; Hourdry J; Remy P
Int J Dev Biol; 1997 Aug; 41(4):607-20. PubMed ID: 9303349
[TBL] [Abstract][Full Text] [Related]
33. The ETS family member Tel antagonizes the Fli-1 phenotype in hematopoietic cells.
Kwiatkowski BA; Zielinska-Kwiatkowska AG; Bauer TR; Hickstein DD
Blood Cells Mol Dis; 2000 Feb; 26(1):84-90. PubMed ID: 10772879
[TBL] [Abstract][Full Text] [Related]
34. The Ets1 proto-oncogene is upregulated by retinoic acid: characterization of a functional retinoic acid response element in the Ets1 promoter.
Raouf A; Li V; Kola I; Watson DK; Seth A
Oncogene; 2000 Apr; 19(15):1969-74. PubMed ID: 10773887
[TBL] [Abstract][Full Text] [Related]
35. Inducible expression of the megakaryocyte-specific gene glycoprotein IX is mediated through an Ets binding site and involves upstream activation of extracellular signal-regulated kinase.
Eisbacher M; Khachigian LM; Khin TH; Holmes ML; Chong BH
Cell Growth Differ; 2001 Aug; 12(8):435-45. PubMed ID: 11504709
[TBL] [Abstract][Full Text] [Related]
36. [Transcription factors and angiogenesis].
Soncin F; Fafeur V; Vandenbunder B
Pathol Biol (Paris); 1999 Apr; 47(4):358-63. PubMed ID: 10372405
[TBL] [Abstract][Full Text] [Related]
37. Regulation of Ets function by protein - protein interactions.
Li R; Pei H; Watson DK
Oncogene; 2000 Dec; 19(55):6514-23. PubMed ID: 11175367
[TBL] [Abstract][Full Text] [Related]
38. Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis.
Valter MM; Hügel A; Huang HJ; Cavenee WK; Wiestler OD; Pietsch T; Wernert N
Cancer Res; 1999 Nov; 59(21):5608-14. PubMed ID: 10554042
[TBL] [Abstract][Full Text] [Related]
39. EAP1/Daxx interacts with ETS1 and represses transcriptional activation of ETS1 target genes.
Li R; Pei H; Watson DK; Papas TS
Oncogene; 2000 Feb; 19(6):745-53. PubMed ID: 10698492
[TBL] [Abstract][Full Text] [Related]
40. Phosphorylation of Ets1 regulates the complementation of a CSF-1 receptor impaired in mitogenesis.
Rabault B; Roussel MF; Quang CT; Ghysdael J
Oncogene; 1996 Aug; 13(4):877-81. PubMed ID: 8761310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
